News Archive
IMS Headlines Archive

Contacts:
Lance Longwell   
IMS Communications
610.834.5338
llongwell@us.imshealth.com

Gail Nielen
IMS Communications
+44  207 393 5103
gnielen@uk.imshealth.com
 
    
IMS Promo.360 Helps Clients Maximize Promotional ROI and Improve Brand Performance Across Markets

FAIRFIELD, CT, November 15, 2005 - IMS Health (NYSE: RX) today announced the launch of IMS Promo.360TM, a powerful portfolio of global offerings that equips pharmaceutical marketing teams with a comprehensive, consistent and tailored approach to promotion management.  The offerings combine the strength of IMS’s global information assets and business expertise to drive improved return on investment of promotional campaigns and enhance brand performance at the local, regional and global levels.

Enabling pharmaceutical decision makers to establish and share benchmarks and best practices, IMS Promo.360 brings together IMS’s industry-leading information, analytics and consulting capabilities to support brand marketing decisions at all stages of product development -- from pre-launch through maturity, for single or multiple brands.  This robust solution features a combination of consulting and syndicated offerings:

“Today, pharmaceutical companies face an increasingly complex array of promotional options, with heightened public scrutiny of promotional investments and declining returns from traditional approaches,” said Mary Beth Lawrence, general manager, IMS Launch and Brand Management.  “IMS offers an integrated, objective view of what’s working and what’s not, across key promotional indicators and markets.  As a result, clients can make more consistent, evidence-based decisions about their promotions – and deliver more effective product messages to physicians and consumers.”
IMS Promo.360 offerings further demonstrate IMS’s commitment to provide the pharmaceutical industry with the breadth and depth of analytical and consulting resources required to improve performance and compete on a global scale. The solutions can be purchased individually or as part of a customized, integrated solution in key promotional markets worldwide.  

 “Promotion management is at a critical crossroads: Face-to-face detailing and sampling are no longer enough to drive market share, and physicians are no longer the ‘single customer,’” said David Gascoigne, practice leader, Promotion Management, IMS Management Consulting. “IMS’s approach enables pharmaceutical brand managers to apply evidence-based analytics and leverage best practices across markets – driving more efficient, effective use of promotional resources.” 

For more information about IMS’s global promotion management services, visit www.imshealth.com/global/promo360 or contact Liz Coyle in the Americas region (610.834.4702), Claude Herinckx in the Europe/Middle East/Africa region (32.2.627.32.53) or Wim Battaerd in the Asia-Pacific region (612.9880.2999).

About IMS
Operating in more than 100 countries, IMS Health is the world's leading provider of information solutions to the pharmaceutical and healthcare industries. With $1.6 billion in 2004 revenue and more than 50 years of industry experience, IMS offers leading-edge business intelligence products and services that are integral to clients’ day-to-day operations, including portfolio optimization capabilities; launch and brand management solutions; sales force effectiveness innovations; managed care and over-the-counter offerings; and consulting and services solutions that improve ROI and the delivery of quality healthcare worldwide. Additional information is available at http://www.imshealth.com.